C27H27FN6O5S — CID 135135833
1-[3-[(8-fluoro-4,4-dimethyl-1,1-dioxo-3H-5,1λ6,2-benzoxathiazepin-2-yl)methyl]phenyl]-5-[(1R,2R)-2-(1-methyltriazol-4-yl)cyclopropyl]pyrazole-4-carboxylic acid (PubChem CID 135135833) has the molecular formula C27H27FN6O5S and a molecular weight of 566.62 g/mol. Its IUPAC name is 1-[3-[(8-fluoro-4,4-dimethyl-1,1-dioxo-3H-5,1λ6,2-benzoxathiazepin-2-yl)methyl]phenyl]-5-[(1R,2R)-2-(1-methyltriazol-4-yl)cyclopropyl]pyrazole-4-carboxylic acid.
| Compound Name | 1-[3-[(8-fluoro-4,4-dimethyl-1,1-dioxo-3H-5,1λ6,2-benzoxathiazepin-2-yl)methyl]phenyl]-5-[(1R,2R)-2-(1-methyltriazol-4-yl)cyclopropyl]pyrazole-4-carboxylic acid |
|---|---|
| PubChem CID | 135135833 |
| Molecular Formula | C27H27FN6O5S |
| Molecular Weight | 566.62 g/mol |
| Exact Mass | 566.17 |
| IUPAC Name | 1-[3-[(8-fluoro-4,4-dimethyl-1,1-dioxo-3H-5,1λ6,2-benzoxathiazepin-2-yl)methyl]phenyl]-5-[(1R,2R)-2-(1-methyltriazol-4-yl)cyclopropyl]pyrazole-4-carboxylic acid |
| SMILES | Cn1cc([C@@H]2C[C@H]2c2c(C(=O)O)cnn2-c2cccc(CN3CC(C)(C)Oc4ccc(F)cc4S3(=O)=O)c2)nn1 |
| InChI | InChI=1S/C27H27FN6O5S/c1-27(2)15-33(40(37,38)24-10-17(28)7-8-23(24)39-27)13-16-5-4-6-18(9-16)34-25(21(12-29-34)26(35)36)20-11-19(20)22-14-32(3)31-30-22/h4-10,12,14,19-20H,11,13,15H2,1-3H3,(H,35,36)/t19-,20-/m1/s1 |
| InChIKey | PPZFGGCBCDRARP-WOJBJXKFSA-N |
| XLogP | 3.47 |
| TPSA | 132.44 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 40 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 566.62 |
| LogP ≤ 5 | 3.47 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |